GlassScriptPhysician profile
Susana Bosques
NPI 1710338793
$428.66
in general payments reported to CMS, 2019-2025
14 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.92 · 2022: $32.91 · 2023: $120 · 2024: $30.04 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $54.34 | 2023-2024 | |
| Janssen Biotech, INC. | $49.92 | 2022-2023 | Symtuza |
| Novo Nordisk INC | $43.55 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $43.09 | 2025 | Mounjaro |
| Amgen INC. | $35.86 | 2025 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $35.70 | 2022-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Viiv Healthcare Company | $26.92 | 2021 | |
| Exact Sciences Corporation | $25.16 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $21.91 | 2023 | |
| Theratechnologies INC. | $21.36 | 2023 | Egrifta, Trogarzo |
| Philips North America LLC | $19.67 | 2025 | Extended Holter |
| Boston Scientific Corporation | $19.56 | 2025 | General - Balloons |
| Pfizer INC. | $17.52 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $14.10 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susana Bosques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.